Financials
- Market Capitalization 22.71 B
- Employee 1 400
- Founded 1996
- CEO N/A
- Website www.unither.com
- Headquarter Delaware, United States
- FIGI BBG000BV4XJ1
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 536 | INSM Insmed Incorporated - Common Stock | 109.07 USD | -5.66% | -2.98% | +13.76% | -32.69% | 23.64 B USD | ||
| 555 | INCY Incyte Corporation - Common Stock | 114.23 USD | -2.12% | -2.81% | +5.50% | +66.10% | 22.82 B USD | ||
| 576 | BNTX BioNTech SE - American Depositary Shares | 90.07 USD | -1.55% | -4.60% | +1.09% | -18.98% | 21.61 B USD | ||
| 659 | ASND Ascendis Pharma A/S - American Depositary Shares | 264.28 USD | -2.28% | -2.18% | +18.82% | +28.87% | 16.38 B USD |
Frequently asked questions about United Therapeutics Corporation - Common Stock
What is the United Therapeutics Corporation - Common Stock stock price today?
The current price of United Therapeutics Corporation - Common Stock (UTHR) is 535.12. Over the past 24 hours, the stock has changed by -2.18%. Follow the UTHR chart for real-time price dynamics.
What is the stock ticker of United Therapeutics Corporation - Common Stock?
United Therapeutics Corporation - Common Stock trades under the ticker UTHR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is United Therapeutics Corporation - Common Stock stock going up?
UTHR has changed by -2.55% over the last week, -2.28% over the last month, and +81.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was United Therapeutics Corporation - Common Stock net income for the last quarter?
United Therapeutics Corporation - Common Stock reported net income of 274.9 M for the last quarter. The previous quarter showed 364.3 M, which means net income changed by -24.54%.
How many employees does United Therapeutics Corporation - Common Stock have?
As of the latest available data, United Therapeutics Corporation - Common Stock has 1 400 employees. Workforce size can provide additional context about the company's scale and operations.
What is United Therapeutics Corporation - Common Stock EBITDA?
United Therapeutics Corporation - Common Stock EBITDA is 348.4 M, and its EBITDA margin is 44.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy United Therapeutics Corporation - Common Stock stock?
You can buy United Therapeutics Corporation - Common Stock (UTHR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in United Therapeutics Corporation - Common Stock stock?
Investing in United Therapeutics Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the UTHR chart and related analysis on metatrader.com as part of your research.